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MaOBJECTIVES The purpose of this study was to assess usage patterns of transradial access in rescue percutaneous
coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) and associations between vascular
access site choice and outcomes.
BACKGROUND Transradial access reduces bleeding and mortality in STEMI patients undergoing primary PCI. Little is
known about access site choice and outcomes in patients undergoing rescue PCI after receiving full-dose ﬁbrinolytic
therapy for STEMI.
METHODS Patients in the National Cardiovascular Data Registry’s CathPCI Registry undergoing rescue PCI for STEMI
between 2009 and 2013 were studied. Patients were divided on the basis of access site. Patterns of access use
and baseline demographics were noted. Unadjusted and propensity-matched analyses were performed comparing
in-hospital bleeding, vascular complications, and mortality outcomes among transradial and transfemoral access
patients. The falsiﬁcation endpoint of gastrointestinal bleeding was speciﬁed to assess for persistent unmeasured
confounding.
RESULTS Transradial access was used in 14.2% of cases. In propensity-matched analyses, transradial rescue PCI was
associated with signiﬁcantly less bleeding than transfemoral access (odds ratio [OR]: 0.67; 95% conﬁdence interval [CI]:
0.52 to 0.87; p ¼ 0.003), but not mortality (OR: 0.81; 95% CI: 0.53 to 1.25; p ¼ 0.35). Gastrointestinal bleeding was less
frequent in the radial group (OR: 0.23; 95% CI: 0.05 to 0.98; p ¼ 0.05).
CONCLUSIONS In a large, “real-world” registry, transradial access was used in a minority of cases and was associated
with signiﬁcantly less bleeding than transfemoral access in patients undergoing rescue PCI. However, given persistent
differences in a falsiﬁcation endpoint, the inﬂuence of treatment-selection bias on these results cannot be ruled out.
Further studies are needed to determine predictors of bleeding and mortality in this understudied high-risk group.
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AB BR E V I A T I O N S
AND ACRONYM S
CI = conﬁdence interval
NCDR = National
Cardiovascular Data Registry
OR = odds ratio
PCI = percutaneous coronary
intervention
STEMI = ST-segment elevation
myocardial infarction
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 1 4 , 2 0 1 5 Kadakia et al.
D E C E M B E R 2 1 , 2 0 1 5 : 1 8 6 8 – 7 6 TR Versus TF Access for Rescue PCI
1869F ibrinolytic therapy is a cornerstone of therapyin patients with ST-segment elevation myocar-dial infarction (STEMI) who present to facil-
ities that do not offer prompt access to primary
percutaneous coronary intervention (PCI). At least
12% to 17% of patients in the United States are treated
with ﬁbrinolytic therapy (1,2). Up to 40% to 50% of
patients do not achieve restoration of Thrombolysis
In Myocardial Infarction ﬂow grade 3 in the infarct-
related artery after administration of full-dose ﬁbri-
nolytic therapy (3,4) and may undergo urgent cardiac
catheterization with coronary intervention, so-called
“rescue PCI.” In the setting of antithrombotic and
antiplatelet agents used to treat acute coronary syn-
dromes, bleeding complications in patients with
STEMI are common and are associated with worse
clinical outcomes and prognosis (5). These risks may
be increased in those receiving ﬁbrinolytic therapy
for STEMI prior to cardiac catheterization (6).
Many of these bleeding complications are related
to the femoral artery access site used for cardiac
catheterization (7).SEE PAGE 1877Several analyses have demonstrated a reduction in
bleeding outcomes in STEMI patients undergoing PCI
via the transradial approach (8–14). However, little is
known about differences in bleeding outcomes on
the basis of access approach in patients undergoing
rescue PCI. Given their high-risk clinical presentation
and the concurrent use of antiplatelet, anticoagulant,
and thrombolytic therapy, these patients may have
the most to gain from “bleeding-avoidance strate-
gies” like radial access. However, patients who fail to
reperfuse with thrombolysis represent a high-risk
subgroup whose procedural success rates may be
worse, and the inﬂuence of transradial access upon
procedural success and mortality in this group is
unknown.
The National Cardiovascular Data Registry (NCDR)
CathPCI Registry provides a unique opportunity to
evaluate access site usage patterns and the differ-
ences in bleeding outcomes and mortality in patients
undergoing transradial versus transfemoral access
following ﬁbrinolytic therapy in STEMI in clinical
practice. We hypothesized that transradial access
would be associated with improved outcomes in
rescue PCI patients.
METHODS
DATA SOURCE AND STUDY SAMPLE. The NCDR
CathPCI Registry is an initiative of the American
College of Cardiology (ACC) Foundation and theSociety for Cardiovascular Angiography and
Interventions. Details of the CathPCI Registry
have been previously described (15,16). The
registry collects demographic, clinical, pro-
cedural, and institutional data elements from
diagnostic catheterizations and PCI at 1,453
participating centers. Data is entered via
a secure web-based platform or software
provided by ACC-approved vendors. There
is a comprehensive data quality program,
including speciﬁcations for data capture and
transmission, education and training for site data
managers, and an auditing program. The data ele-
ments and deﬁnitions were created by a specially
assigned ACC committee. The data collection form
and a comprehensive description of the data ele-
ments are available online (17).
The study population included adult (age >18
years) patients presenting with STEMI initially
treated with ﬁbrinolytic therapy who subsequently
underwent rescue PCI via either a transfemoral or
transradial approach from July 1, 2009, to June 30,
2013. Rescue PCI was deﬁned as PCI for STEMI after
failed full-dose ﬁbrinolytic therapy. The following
patients were excluded: those who required femoral
access for intra-aortic balloon pump or other me-
chanical ventricular support; those who underwent
in-hospital coronary artery bypass surgery; those who
underwent >1 PCI during the index hospitalization;
those on hemodialysis; and patients who underwent
catheterization >72 h after ﬁbrinolytic administra-
tion. Following these exclusions, 9,494 patients from
603 sites were included in this analysis (Figure 1).
ENDPOINTS AND DEFINITIONS. The primary endpoint
for this analysis was bleeding complications. Bleeding
was deﬁned as the presence of 1 or more of the
following within 72 h of PCI: overt access site bleeding,
retroperitoneal hemorrhage, intracranial hemorrhage,
gastrointestinal or genitourinary bleeding, cardiac
tamponade, non–bypass surgery-related blood trans-
fusion in patients with a pre-procedure hemoglobin
#8 g/dl, or an absolute decrease in hemoglobin$3 g/dl
from pre- to post-PCI in patients with a pre-procedure
hemoglobin value of <16 g/dl. Secondary endpoints
were in-hospital mortality and other vascular compli-
cations requiring treatment.
STATISTICAL ANALYSIS. Patient and hospital char-
acteristics were compared by vascular access site used
for rescue PCI (radial vs. femoral). These included
patient demographics, medical history, risk factors,
intraprocedural and post-procedural events, lesions
and devices, discharge, and hospital characteristics.
Categorical variables are presented as frequencies
FIGURE 1 Patient Selection Process
Patient population from the CathPCI Registry selected for the study displayed as a CON-
SORT diagram. CABG ¼ coronary artery bypass surgery; IABP ¼ intra-aortic balloon pump;
PCI ¼ percutaneous coronary intervention; STEMI ¼ ST-segment elevation myocardial
infarction.
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1870(percentages), and differences were assessed using
the chi-square test. Continuous variables are pre-
sented as medians with interquartile ranges and were
compared using the Wilcoxon rank-sum test.
We accounted for potential selection bias in those
who underwent transradial versus transfemoral pro-
cedures by constructing a propensity model
for vascular access using logistic regression. Variables
were selected a priori in a nonparsimonious fashion
from the NCDR CathPCI version 4 pre-catheterization
in-hospital mortality and bleeding models (8,18).
Speciﬁcally, we adjusted for sex, age, race, body mass
index (BMI), hypertension, hyperlipidemia, family
history of premature coronary artery disease, prior
myocardial infarction, heart failure history, cerebro-
vascular disease, peripheral vascular disease, prior
PCI, prior coronary artery bypass graft, diabetes,
tobacco use, history of dialysis, glomerular ﬁltration
rate, heart failure on presentation (New York Heart
Association functional class), cardiac arrest, aspirin
use, thienopyridine use, anticoagulant, glycoprotein
(GP) IIb/IIIa use, pre-procedure hemoglobin (as a
continuous linear spline with 1 knot at 13), time fromsymptom onset to presentation, and time from ﬁbri-
nolytic therapy to procedure time. Pre– and post–
inverse probability of treatment weighting (IPTW)
balance of the covariates between radial and femoral
patients was also checked.
To determine the association between radial
versus femoral PCI and in-hospital outcomes, logistic
regression with generalized estimating equations to
account for within hospital clustering was used. The
propensity to undergo radial or femoral access was
included in the model by inverse probability of
treatment weighting. Weights were stabilized using
the marginal probability of radial access to maximize
efﬁciency. For radial patients, the weights were
calculated by dividing the marginal probability of
radial access by the individual patient’s propensity
score. Weights for femoral access patients were
calculated as: (1  marginal probability of radial
access)/(1  individual patient’s propensity score).
Pre- and post-IPTW balance of the covariates
between treatment groups was assessed using
Cramer’s phi for categorical variables and R2 for
continuous variables. Values closer to 0 indicated
better balance. After IPTW adjustment, the Cramer’s
phi measure for each categorical variable except for
history of prior coronary bypass surgery was <0.035
and the R2for each continuous variable was <0.003
(Figure 2). IPTW-adjusted subgroup analysis was per-
formed in several key subgroups, including age >75
years, male sex, BMI $30 kg/m2, diabetic patients,
creatinine clearance <45 ml/min, GP IIb/IIIa use,
bivalirudin use, and cardiogenic shock. Given the
known issue of residual confounding in observational
analyses of radial versus femoral access (19), we tested
a falsiﬁcation endpoint of gastrointestinal bleeding on
both groups. This endpoint served as a “negative
control” in our analysis, as rates of gastrointestinal
bleeding were unlikely to be inﬂuenced by the choice
of access site. To further examine the role of baseline
differences in bleeding risk between the 2 cohorts, we
performed an analysis to ascertain the pre-procedure
predicted bleeding risk of the 2 groups on the basis
of a validated NCDR CathPCI bleeding risk model (20).
All analyses were performed by the Duke Clinical
Research Institute using SAS version 9.3 (SAS Insti-
tute, Cary, North Carolina). This study was approved
by the Duke University Medical Center institutional
review board and was determined to meet the deﬁ-
nition of research not requiring informed consent.
RESULTS
BASELINE CHARACTERISTICS AND TREATMENT.
Among 9,494 patients undergoing rescue PCI
FIGURE 2 Covariate Balance Before and After Propensity Matching
Pre– and post–inverse probability of treatment weighting (IPTW) balance of the covariates
between radial and femoral patients for categorical variables (A) and continuous variables (B).
GFR¼ glomerular ﬁltration rate; HF ¼ heart failure; NYHA ¼ New York Heart Association;
PCI ¼ percutaneous coronary intervention.
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1871following ﬁbrinolytic therapy for STEMI, 8,146 (85.8%)
had femoral access and 1,348 (14.2%) had radial
access. Those undergoing radial access were more
often younger and male, and more often had
higher BMI, family history of coronary artery dis-
ease, and history of congestive heart failure. They
less often had a history of hypertension, dyslipide-
mia, previous coronary artery bypass graft surgery,
cerebrovascular disease, or chronic lung disease
(Table 1).
On presentation, patients undergoing radial access
less often had heart failure within the 2 weeks prior to
presentation, cardiogenic shock, and cardiac arrest.
Mean glomerular ﬁltration rate was higher in the
radial access group. There was no statistically signif-
icant difference in baseline hemoglobin levels. The
median time from ﬁbrinolytic administration to car-
diac catheterization was 189 min (interquartile range:
108 to 918 min). There were no differences in ejection
fraction between the 2 groups. Radial access patients
more often received aspirin and unfractionated
heparin. There were no other statistically signiﬁcant
differences in medical therapies between the 2
groups, including usage of thienopyridines and GP
IIb/IIIa inhibitors (Table 2).
Patients treated with transradial access had lower
pre-procedure predicted bleeding risk scores (10.2 
8.2%) than those treated with transfemoral access
(12.02  8.5%) on the basis of a validated NCDR
CathPCI bleeding risk model (p < 0.0001) (20).
ACCESS APPROACH AND CLINICAL OUTCOMES.
Fluoroscopy time was longer in the radial access
group (14.4  10.4 min vs. 12.1  9.2 min; p < 0.0001).
Contrast volume was greater in femoral access
patients (197.1  84.2 ml vs. 180.9  78.4 ml;
p < 0.0001). There was no statistically signiﬁcant
difference in successful dilatation of the culprit lesion
(96.1% in radial access patients vs. 94.7% in femoral
patients; p ¼ 0.06) (Table 2).
Unadjusted analysis demonstrated a signiﬁcantly
lower incidence of the primary bleeding endpoint in
the radial access group compared with the femoral
access group (6.9% vs. 12.0%; p < 0.0001). The
number needed to treat to prevent 1 bleeding
complication with the radial approach was 20.
There were fewer blood transfusions (1.1% vs. 2.8%;
p ¼ 0.0003), vascular complications (0% vs. 0.4%;
p ¼ 0.02), access site bleeding events (0.2% vs. 1.1%;
p ¼ 0.001), access site hematomas (0.22% vs. 1%;
p ¼ 0.004), and retroperitoneal bleeding events (0%
vs. 0.4%; p ¼ 0.02) in the radial access group. There
was also a borderline associated mortality beneﬁt
in the radial group (1.7% vs. 2.6%; p ¼ 0.05) (Table 3).IPTW-adjusted analysis demonstrated that radial
access was associated with signiﬁcantly less bleeding
than femoral access (odds ratio [OR]: 0.67; 95% con-
ﬁdence interval [CI]: 0.52 to 0.87; p ¼ 0.003).
In-hospital mortality was not signiﬁcantly different
between the groups (OR: 0.81; 95% CI: 0.53 to 1.25;
p ¼ 0.35) (Figure 3). IPTW-adjusted subgroup analyses
in several key subgroups were consistent with the
overall results (Figure 4).
The falsiﬁcation endpoint of gastrointestinal
bleeding demonstrated less gastrointestinal bleeding
in the radial group after IPTW adjustment (OR: 0.23;
95% CI: 0.05 to 0.98; p ¼ 0.05).
TABLE 1 Demographics and Prior History of Study Patients
Radial
(n ¼ 1,348)
Femoral
(n ¼ 8,146) p Value
Age 57.4  11.2 58.9  11.8 <0.0001
Sex 1,069 (79) 6,160 (76) 0.0033
BMI, kg/m2 30.3  6.2 29.7  6.0 0.0004
Previous MI 207 (15) 1,406 (17) 0.08
Previous CHF 28 (2) 270 (3) 0.02
Diabetes 307 (23) 1,825 (22) 0.75
Cerebrovascular disease 54 (4) 442 (5) 0.03
Peripheral vascular disease 63 (5) 363 (4) 0.72
Chronic lung disease 114 (8) 842 (10) 0.03
Hypertension 817 (61) 5,188 (64) 0.03
Current/recent smoker 664 (49) 3,987 (49) 0.8
Dyslipidemia 750 (56) 4,922 (60) 0.001
Family history of CAD at age <55 yrs 324 (24) 1,743 (21) 0.03
Previous PCI 220 (16) 1,430 (18) 0.27
Previous CABG 23 (2) 450 (6) <0.0001
GFR 82.8  25.4 79.7  30.3 <0.0001
Values are mean  SD or n (%).
BMI ¼ body mass index; CABG ¼ coronary artery bypass graft surgery; CAD ¼ coronary artery
disease; CHF ¼ congestive heart failure; GFR ¼ glomerular ﬁltration rate (using the Modiﬁcation
of Diet in Renal Disease study equation); MI ¼myocardial infarction; PCI ¼ percutaneous coronary
intervention.
TABLE 2
Study Pa
Heart fail
Cardiogen
Cardiac a
Fluorosco
Contrast
Ejection f
Aspirin
Clopidog
Prasugrel
Unfractio
Bivalirudi
Low-mol
GP IIb/III
Values are
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We found that the majority of patients in the United
States undergoing rescue PCI following ﬁbrinolytic
therapy for STEMI have the procedure performed via
the transfemoral approach. In patients undergoing
radial catheterization in this setting, procedural suc-
cess rates were high. Our primary analyses demon-
strated lower associated bleeding risk in patients
undergoing rescue PCI via the transradial approach,Clinical Presentation and Concomitant Medical Treatments of
tients
Radial
(n ¼ 1,348)
Femoral
(n ¼ 8,146) p Value
ure within 2 weeks 58 (4) 502 (6) 0.007
ic shock 41 (3) 456 (6) <0.0001
rrest 74 (5) 665 (8) 0.0007
py time 14.4  10.4 12.1  9.2 <0.0001
volume 180.9  78.4 197.13  84.2 <0.0001
raction 47.0  11.7 46.4  11.3 0.17
1,257 (94) 7,349 (91) 0.0007
rel 1,002 (74) 6,013 (74) 0.79
213 (16) 1,143 (14) 0.34
nated heparin 1,150 (85) 6,347 (78) <0.0001
n 450 (33) 2,625 (32) 0.38
ecular-weight heparin 230 (17) 1,475 (18) 0.36
a inhibitor 424 (32) 2,753 (34) 0.10
n (%) or mean  SD.
coprotein.and this may be an underutilized bleeding avoidance
strategy in this understudied patient population.
We observed a “risk-treatment paradox” with the
utilization of transradial access, as patients treated
with this approach had signiﬁcantly lower pre-
procedure predicted bleeding risk scores. Despite
the utilization of a nonparsimonious propensity-
matched model, persistent differences in the falsiﬁ-
cation endpoint of gastrointestinal bleeding between
the groups point to the presence of unmeasured
confounders inﬂuencing our adjusted outcomes.
Hence, our results must be interpreted as hypothesis-
generating.
Several prior studies have examined bleeding
outcomes with transradial access for STEMI,
although nearly all of these studies have either
excluded or not speciﬁcally analyzed rescue PCI
patients. Two prior randomized trials and a large
registry analysis have demonstrated improvements
in outcomes with utilization of transradial access in
primary PCI, but rescue PCI patients were excluded
from these studies (11,12,14). The RIFLE-STEACS
(Radial Versus Femoral Randomized Investigation
in ST-Elevation Acute Coronary Syndrome) trial
randomized 1,001 STEMI patients to radial or
femoral access and found lower mortality, bleeding,
and length of hospital stay in the radial access
group. Similarly, a prior NCDR CathPCI registry–
based analysis of 91,000 United States patients
found lower adjusted risk of bleeding and in-
hospital mortality in radial access patients com-
pared with femoral access patients (8). Although
rescue PCI patients were included in these 2 studies,
outcomes speciﬁc to this important group were not
examined.
Only 2 prior analyses have attempted to address
differences in clinical outcomes between rescue PCI
patients treated with varying access strategies. A
2004 study retrospectively examined transradial
versus transfemoral access in 111 patients undergoing
rescue PCI with adjuvant GP IIb/IIIa use (21). Addi-
tionally, a 2007 study examined 287 patients under-
going rescue PCI, 44 of whom underwent transradial
access (22). Both studies suggested improvements
in bleeding outcomes with use of transradial access.
However, these studies were unadjusted analyses
that were modest in size.
To our knowledge, there has been no large trial
or observational analysis with statistical adjustment
that has analyzed the association of access approach
with bleeding complications and mortality specif-
ically in STEMI patients treated with ﬁbrinolytic
therapy who have undergone rescue PCI. The current
analysis also represents by far the largest population
FIGURE 3 Adjusted Outcomes of Transradial Versus Transfemoral Access
Association between transradial access and in-hospital outcomes, including mortality and
the composite bleeding endpoint. Odds ratios and 95% conﬁdence intervals listed on the
right side of the ﬁgure.
TABLE 3 Clinical and Bleeding Outcomes of Study Participants
Radial
(n ¼ 1,348)
Femoral
(n ¼ 8,146) p Value
Lesion successfully dilated 1,295 (96.1) 7,710 (94.7) 0.06
Any vascular complication 0 (0) 33 (0.4) 0.02
RBC/whole blood transfusion 15 (1.1) 227 (2.8) 0.0003
Bleeding event within 72 h 18 (1.3) 304 (3.7) <0.0001
Bleeding at percutaneous entry site 2 (0.2) 86 (1.1) 0.001
Hematoma at access site 3 (0.22) 83 (1) 0.004
Retroperitoneal bleeding 0 (0) 33 (0.4) 0.02
Gastrointestinal bleeding 2 (0.2) 69 (0.9) 0.006
Overall bleeding 93 (7) 967 (12) <0.0001
Death 23 (1.7) 212 (2.6) 0.05
Values are n (%).
RBC ¼ red blood cell.
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1873of rescue PCI patients ever studied. Moreover, many
prior analyses of access approach are based on clinical
trial populations, which exclude the elderly and
patients with signiﬁcant comorbidities who have
increased risk of bleeding and in whom pharmaco-
logical reperfusion is less commonly employed
(23–25). Our analysis avoids these pitfalls through
examination of a contemporary patient population
across a nationally representative group of hospitals.
Patients undergoing primary PCI for STEMI are at
increased risk of bleeding (20), and this risk may be
increased in those who receive ﬁbrinolytic therapy
prior to PCI (6). Bleeding has been associated with
increased mortality in patients presenting with acute
coronary syndromes (26). Thus, the reduction of
bleeding in this group of patients is of particular
interest. Despite possible reductions in bleeding
via the transradial approach, our data indicates
that 85% of patients undergoing rescue PCI are
approached via the transfemoral access route. Addi-
tionally, patients chosen for treatment with trans-
radial access were actually at lower predicted
bleeding risk than those chosen for transfemoral
access. This “risk-treatment paradox” in the use of
transradial access for PCI has been noted in other
studies (27). Our ﬁndings may be due to a lack of
operator comfort with the transradial approach, lack
of awareness of the beneﬁts of transradial approach,
and facility/catheterization laboratory staff unfamil-
iarity with radial setup leading to delays in time-
sensitive situations such as acute myocardial
infarction. Multiple societies aim to educate and in-
crease U.S. operator utilization of the radial approach,
particularly for higher-risk patient populations
(28,29).
Of note, there were no associated improvements in
in-hospital mortality observed in the current study.
This is in contrast to prior ﬁndings from the NCDR
that examined all patients presenting with STEMI
treated with radial access (8), although it is consistent
with the more recent STEMI-RADIAL (ST Elevation
Myocardial Infarction treated by RADIAL or femoral
approach) trial (30). It is likely that the currently
examined rescue PCI population represents a group at
intermediate risk of mortality as compared with the
STEMI population as a whole. Our patient cohort had
lower in-hospital mortality rates (1% to 2%) than all-
comers with STEMI (5.5%) (1). In particular, patients
requiring intra-aortic balloon pump or those requiring
multiple PCIs were excluded from our analysis,
because these procedures require additional access
sites that could confound bleeding outcomes. As
such, the current population may have more in
common with non-STEMI and elective PCIpopulations that have lower PCI-related rates of
mortality. In these groups, despite beneﬁt in terms of
bleeding and vascular complications, the mortality
beneﬁt of transradial access has been less clear (30).
Another possibility is that the post-thrombolytic
milieu may create a more favorable environment
that leads to less distal embolization and no-reﬂow
phenomenon, improving mortality to such a degree
that it eliminates the propensity-matched mortality
beneﬁt in the radial group. Alternatively, given the
low in-hospital mortality rates seen in the present
analysis, it is possible that we did not have the power
to accurately assess mortality in this patient group.
Our ﬁndings raise several interesting questions
for future research and development in the under-
studied rescue PCI population. Other bleeding
avoidance strategies, such as the use of bivalirudin,
have been shown to reduce bleeding in STEMI, but
have not been studied speciﬁcally in the rescue PCI
population (31). Importantly, in our analysis, even in
FIGURE 4 Adjusted Bleeding Outcomes in Subgroups of Interest
Association between transradial access and bleeding in key subgroups. Odds Ratios and
95% conﬁdence intervals listed on the right side of the ﬁgure. BMI ¼ body mass index;
CrCl ¼ creatinine clearance; GP ¼ glycoprotein.
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1874the subgroup of patients receiving bivalirudin, there
was a sustained reduction in bleeding outcomes
suggesting an added beneﬁt of transradial access over
bivalirudin alone. Additionally, we found increases in
ﬂuoroscopy time with radial access among rescue PCI
patients, consistent with prior analyses of both PCI
and diagnostic catheterization via the transradial
approach (32,33). Although not associated with dif-
ferences in overall procedural success, this consistent
ﬁnding across studies does underscore the need for
continuing technological development that facilitates
transradial procedures as well as continuing educa-
tion to increase operator experience and skill from
the transradial approach.
STUDY LIMITATIONS. We speciﬁed a falsiﬁcation
endpoint of gastrointestinal bleeding to formally
assess for possible residual confounding in this
observational analysis. Despite robust statistical
adjustment and the use of a nonparsimonious pro-
pensity model, there may still be unmeasured resid-
ual confounders in the association among patient
characteristics, access approach, and outcomes.
This is reﬂected by the persistent difference in a
bleeding outcome that is unlikely to be directly
related to access approach (gastrointestinal bleeding)
between the 2 groups after IPTW adjustment. This is
an issue that may be particularly relevant to studiesof radial versus femoral access that have been shown
to experience possible residual confounding when
assessed by falsiﬁcation endpoints (19). It has proven
difﬁcult to obviate this residual confounding despite
varying methods of statistical adjustment. The results
of our falsiﬁcation endpoint analysis demonstrate
the necessity of employing more stringent method-
ologies to cardiovascular observational analyses to
produce valid data that is unlikely to be contradicted
by subsequent randomized studies.
In addition to possible residual confounding, our
study has limitations inherent to registry analysis.
The examined registry only contained data regarding
in-hospital mortality. It is possible that radial access
could confer a mortality beneﬁt over the longer term
(30 days or 2 years), as has been suggested by prior
studies of radial access in STEMI (11,13,14). Addi-
tionally, it is possible that all bleeding outcomes were
not captured, as the data is based on self-reporting by
participating hospitals. Although the NCDR conducts
a robust auditing program, all outcomes are not
independently adjudicated as is the case in many
randomized trials. Access site was recorded as the
primary access site, and data on access-site crossover
was not available. The dataset is limited to those
that report to the CathPCI registry. Although this
includes the largest contemporary group of in-
stitutions in the world performing PCI and does
reﬂect a variety of hospitals by size, location, private/
public, and academic/nonacademic, it does not reﬂect
all hospitals in the United States. Finally, analyzed
data are only from the United States, and global
practice patterns likely vary.
CONCLUSIONS
In a large, “real-world” registry, transradial access
was used in 15% of patients undergoing rescue PCI
with high procedural success rates. Propensity-
matched analyses suggested signiﬁcantly less
bleeding associated with a transradial approach in
this population. Given persistent differences in a
falsiﬁcation endpoint, the inﬂuence of treatment-
selection bias on these results cannot be ruled out.
However, given the lack of research regarding
bleeding avoidance in rescue PCI, the present study
is likely to represent the best available data in this
area for the foreseeable future.
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PERSPECTIVES
WHAT IS KNOWN? Although radial access has been
shown to reduce bleeding and mortality in STEMI, little is
known about the role of radial access in rescue PCI.
WHAT IS NEW? Using the NCDR CathPCI Registry, we
examined 9,494 STEMI patients undergoing rescue PCI
and found that 14.3% of procedures were performed with
radial access. IPTW-adjusted analysis demonstrated a
signiﬁcantly lower risk of bleeding in the radial access
group (OR: 0.67; 95% CI: 0.52 to 0.87; p ¼ 0.003), but
no difference in in-hospital mortality (OR: 0.93; 95% CI:
0.61 to 1.44; p ¼ 0.75). Gastrointestinal bleeding was
also less frequent in the radial group (OR: 0.23; 95% CI:
0.05 to 0.98; p ¼ 0.05) making it impossible to rule out
the effect of unmeasured confounders on this analysis.
WHAT IS NEXT? Given the lack of research regarding
bleeding avoidance in rescue PCI, the present study is
likely to represent the best available data in this area for
the foreseeable future.
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